Literature DB >> 15846461

Covariate detection in population pharmacokinetics using partially linear mixed effects models.

Peter L Bonate1.   

Abstract

PURPOSE: To introduce partially linear mixed effects models (PLMEMs), to illustrate their use, and to compare the power and Type I error rate in detecting a covariate effect with nonlinear mixed effects modeling using NONMEM.
METHODS: Sparse concentration-time data from males and females (1:1) were simulated under a 1-compartment oral model where clearance was sex-dependent. All possible combinations of number of subjects (50, 75, 100, 150, 250), samples per subject (2, 4, 6), and clearance multipliers (1 to 1.25) were generated. Data were analyzed with and without sex as a covariate using PLMEM (maximum likelihood estimation) and NONMEM (first-order conditional estimation). Four covariate screening methods were examined: NONMEM using the likelihood ratio test (LRT), PLMEM using the LRT, PLMEM using Wald's test, and analysis of variance (ANOVA) of the empirical Bayes estimates (EBEs) for CL treating sex as a categorical variable. The percent of simulations rejecting the null hypothesis of no covariate effect at the 0.05 level was determined. 300 simulations were done to calculate power curves and 1000 simulations were done (with no covariate effect) to calculate Type I error rate. Actual implementation of PLMEMs is illustrated using previously published teicoplanin data.
RESULTS: Type I error rates were similar between PLMEM and NONMEM using the LRT, but were inflated (as high as 36%) based on PLMEM using Wald's test. Type I error rate tended to increase as the number of observations per subject increased for the LRT methods. Power curves were similar between the PLMEM and NONMEM LRT methods and were slightly more than the power curve using ANOVA on the EBEs of CL. 80% power was achieved with 4 samples per subject and 50 subjects total when the effect size was approximately 1.07, 1.07, 1.08, and 1.05 for LRT using PLMEMs, LRT using NONMEM, ANOVA on the EBEs, and Wald's test using PLMEMs, respectively.
CONCLUSIONS: PLMEM and NONMEM covariate screening using the LRT had similar Type I error rates and power under the data generating model. PLMEMs offers a viable alternative to NONMEM-based covariate screening.

Entities:  

Mesh:

Year:  2005        PMID: 15846461     DOI: 10.1007/s11095-005-2492-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  5 in total

1.  A brief introduction to Monte Carlo simulation.

Authors:  P L Bonate
Journal:  Clin Pharmacokinet       Date:  2001-01       Impact factor: 6.447

2.  An approximate distribution of estimates of variance components.

Authors:  F E SATTERTHWAITE
Journal:  Biometrics       Date:  1946-12       Impact factor: 2.571

3.  A semiparametric method for describing noisy population pharmacokinetic data.

Authors:  K Park; D Verotta; T F Blaschke; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1997-10

4.  Comparing non-hierarchical models: application to non-linear mixed effects modeling.

Authors:  E I Ette
Journal:  Comput Biol Med       Date:  1996-11       Impact factor: 4.589

5.  Pharmacokinetics of a single dose of teicoplanin in burn patients.

Authors:  J A Steer; R P Papini; A P Wilson; S Dhillon; M F Hichens; D A McGrouther; J D Frame; N Parkhouse
Journal:  J Antimicrob Chemother       Date:  1996-03       Impact factor: 5.790

  5 in total
  4 in total

1.  Design of pharmacokinetic studies for latent covariates.

Authors:  Chakradhar V Lagishetty; Carolyn V Coulter; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-12-10       Impact factor: 2.745

2.  Utility of a Bayesian Mathematical Model to Predict the Impact of Immunogenicity on Pharmacokinetics of Therapeutic Proteins.

Authors:  Steven Kathman; Theingi M Thway; Lei Zhou; Stephanie Lee; Steven Yu; Mark Ma; Naren Chirmule; Vibha Jawa
Journal:  AAPS J       Date:  2016-01-19       Impact factor: 4.009

3.  Pharmacogenetics and population pharmacokinetics: impact of the design on three tests using the SAEM algorithm.

Authors:  Julie Bertrand; Emmanuelle Comets; Céline M Laffont; Marylore Chenel; France Mentré
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-06-27       Impact factor: 2.745

4.  Powers of the likelihood ratio test and the correlation test using empirical bayes estimates for various shrinkages in population pharmacokinetics.

Authors:  F P Combes; S Retout; N Frey; F Mentré
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-04-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.